SCHEMBL2221655

SCHEMBL2221655

C[N+](C)(C)CCOC(=O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.65
TDP1 Q9NUW8 2/20 0.63
BCHE P06276 1/20 0.60
ACHE P22303 1/20 0.60
CHRM2 P08172 2/20 0.60
CHRM4 P08173 2/20 0.60
CHRM1 P11229 2/20 0.60
CHRM3 P20309 2/20 0.60
MAPK1 P28482 1/20 0.52
HIF1A Q16665 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A3 Q01959 1/20 0.52
KMT2A Q03164 1/20 0.52
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
APOBEC3A P31941 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL2353854 0.98 LMNA (0.62) LMNATDP1BCHEACHECHRM2
Hydrochloric Acid SCHEMBL2356481 0.98 LMNA (0.62) LMNATDP1BCHEACHECHRM2
Bromide SCHEMBL2356769 0.98 LMNA (0.62) LMNATDP1BCHEACHECHRM2
Water SCHEMBL16320769 0.98 LMNA (0.62) LMNATDP1BCHEACHECHRM2
Urea SCHEMBL27927742 0.95 LMNA (0.59) LMNATDP1BCHEACHECHRM2
SCHEMBL16353089 0.90 CHRM2 (0.54) LMNATDP1BCHEACHECHRM2
SCHEMBL28558488 0.90 BCHE (0.58) LMNATDP1BCHEACHECHRM2
SCHEMBL13601165 0.89 TDP1 (0.70) LMNATDP1BCHEACHECHRM2
Bromide SCHEMBL9480622 0.87 LMNA (0.62) LMNATDP1BCHEACHECHRM2
SCHEMBL9540358 0.84 LMNA (0.59) LMNATDP1BCHEACHECHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119215983-A Quaternary ammonium salt ionic liquid catalyst for synthesizing diether fluorene and preparation method thereof 濮阳市盛通聚源新材料有限公司 2024-12-31 CN claimed
WO-2024196901-A2 A HIGH THROUGHPUT ION-SENSING METHOD WHITESIDES GEORGE M (US) 2024-09-26 WO claimed
US-11406100-B2 Acellular collagenous tissue and a processing method of artificial heart valve comprising the acellular collagenous tissue KINGSTRONBIO (CHANGSHU) CO., LTD. (CN) 2022-08-09 US claimed
EP-3123860-B1 ACELLULAR COLLAGENOUS TISSUE AND PROCESSING METHOD OF ARTIFICIAL VALVE COMPRISING ACELLULAR COLLAGENOUS TISSUE KINGSTRONBIO CHANGSHU CO LTD (CN) 2020-02-12 EP claimed
CN-106729677-A Treat pharmaceutical composition of Pulmonary Tuberculosis Combined with Diabetes and preparation method thereof 济南昊雨青田医药技术有限公司 2017-05-31 CN claimed
EP-3123860-A1 ACELLULAR COLLAGENOUS TISSUE AND PROCESSING METHOD OF ARTIFICIAL VALVE COMPRISING ACELLULAR COLLAGENOUS TISSUE Kingstronbio (Changshu) Co., Ltd. (CN) 2017-02-01 EP claimed
US-20170006858-A1 ACELLULAR COLLAGENOUS TISSUE AND A PROCESSING METHOD OF ARTIFICIAL HEART VALVE COMPRISING THE ACELLULAR COLLAGENOUS TISSUE KINGSTRONBIO (CHANGSHU) CO., LTD. (CN) 2017-01-12 US claimed
CN-104023526-B A kind ofly process the method for biomaterial and the biomaterial through the method process KINGSTRONBIO (CHANGSHU) Co.,Ltd. (CN) 2016-01-13 CN claimed
CN-104023526-A Biological material processing method, and biological material processed through the same JINSHI BIOTECHNOLOGY CHANGSHU CO LTD 2014-09-03 CN claimed
CN-101058745-B Removal and recovery of naphthenic acid in oil based on ion switch principle INST PROCESS ENG CAS 2011-09-07 CN claimed
US-20050232864-A1 Method for phenotyping using nmr spectroscopy OXFORD INSTRUMENTS MOLECULAR BIOTOOLS LIMITED (GB) 2005-10-20 US claimed
EP-1501940-A1 METHOD FOR PHENOTYPING USING NMR SPECTROSCOPY Amersham Health AS (NO) 2005-02-02 EP claimed
EP-1497448-A1 METHODS AND COMPOUND MIXTURES FOR DETERMINING PROTEIN ACTIVITY USING NMR SPECTROSCOPY Amersham Health AS (NO) 2005-01-19 EP claimed
WO-2003089656-A1 METHODS AND COMPOUND MIXTURES FOR DETERMINING PROTEIN ACTIVITY USING NMR SPECTROSCOPY AMERSHAM HEALTH AS (NO) 2003-10-30 WO claimed
WO-2003089657-A1 METHOD FOR PHENOTYPING USING NMR SPECTROSCOPY AMERSHAM HEALTH AS (NO) 2003-10-30 WO claimed
EP-0657545-B1 Assay method for biological components DAIICHI PURE CHEMICALS CO LTD (JP) 2003-08-06 EP claimed
EP-0674232-B1 Recording sheets XEROX CORP (US) 2000-05-31 EP claimed
EP-0674233-B1 Recording sheets XEROX CORP (US) 2000-05-24 EP claimed
US-5559003-A BILIRUBIN INTERFERENCE DAIICHI PURE CHEMICALS CO., LTD. (JP) 1996-09-24 US claimed
US-4135980-A PREPARATION BY CULTURING MICROORGANISM OF GENUS ARTHROBACTER, USE IN DETERMINATION OF CHOLINE OR BETAINE ALDEHYDE TOYO JOZO KABUSHIKI KAISHA (JP) 1979-01-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050232864-A1 Method for phenotyping using nmr spectroscopy TSPO, FABP3, HNRNPA3 LMNA 1468/4885TDP1 2292/4885BCHE 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.